Biotech

All Articles

OS Therapies refiles $6M IPO to fund HER2 drug, preclinical ADCs

.Operating system Therapies are going to provide on the NYSE American stock swap today by means of a...

ALX's fizzling CD47 reaction rate delivers stock spiraling down

.ALX Oncology's period 2 stomach cancer cells feedback fee has damaged. After finding its CD47 block...

Ionis centers eye condition from targets of Roche-partnered prospect after information dissatisfy

.Yet Another of Ionis Pharmaceuticals' essential midphase readouts has actually disappointed require...

Biogen's chief executive officer said no high-risk handle 2023. He's ready to become strong

.While Biogen's pharma peers are actually searching for late-stage possessions along with little ris...

Instil refills pipeline in $2B biobucks manage ImmunOnco

.Instil Biography has been actually a biotech searching for a pipeline after it junked its own lead ...

Biogen bows out Denali Alzheimer's collab

.Biogen has returned rights to a very early Alzheimer's condition program to Denali Therapeutics, le...

Takeda faucets brand new head of US oncology service-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of notable leadership hirings, shootings as well...

Vertex, hammered by AATD once more, falls 2 assets on throw away stack

.Tip's attempt to deal with an uncommon genetic health condition has actually reached an additional ...

Vir gains 3 T-cell engagers from Sanofi, lays off 25% of team

.Vir Biotechnology's second-quarter profits file had not been except big news. The company welcomed ...

Galapagos stops briefly CAR-T cell therapy trial over Parkinsonism situation

.Galapagos has actually stopped briefly registration in a trial of a BCMA-directed CAR-T tissue ther...